Filing Details
- Accession Number:
- 0001179929-17-000162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-05 17:52:41
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-07-05
- Accepted Time:
- 2017-07-05 17:52:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1179929 | Molina Healthcare Inc | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305822 | Terry Bayer | 300 University Avenue, Suite 100 Sacramento CA 95825 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-30 | 350 | $54.26 | 80,672 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-07-03 | 415 | $69.24 | 80,257 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were acquired under the Molina Healthcare, Inc. 2011 Employee Stock Purchase Plan.
- Represents the closing price of Issuer's common stock on December 30, 2016. The purchase price is based on the stock's lower market price as of the two following dates: (1) January 1, 2017, the first day of the ESPP offering period, and (2) June 30, 2017, the last day of the ESPP offering period.
- The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on May 12, 2017. The sale previously reported on June 14, 2017 was also pursuant to the Reporting Person's 10b5-1 Plan established on May 12, 2017, not the 10b5-1 Plan established on March 15, 2017.
- Represents the actual selling price for all 415 shares.
- The shares vest as follows: (i) 16,033 shares shall vest in one-third increments over three years, on each of March 1, 2018, March 1, 2019, and March 1, 2020; (ii) 5,154 shares shall vest based on the Company's 2017 after tax profit margin; (iii) 5,154 shares shall vest based on the Company's 2018 after tax profit margin; (iv) 5,154 shares shall vest based upon the Company's 2017 STARS ratings; (v) 7,731 shares shall vest upon the Company's achievement of certain business development targets; (vi) 10,309 shares shall vest in two increments on each of March 7, 2018 and March 7, 2019; continued
- (vii) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (viii) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; (ix) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (x) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (xi) 2,866 shares shall vest on April 1, 2018; the remainder of the shares are vested.